Ligand validation:8AUN

L9I: ethyl (2Z)-2-hydroxyimino-3-oxidanylidene-butanoate

L9I is a Ligand Of Interest in 8AUN designated by the Author

	Best-fitted instance in this entry
	Other instances in this entry

	Best-fitted instance in this entry
	Best-fitted PDB instances with same target (top 5)

	Best-fitted instance in this entry
	Best-fitted PDB instances with different target (top 5)

Identifier	Ranking for goodness of fit	Ranking for geometry	Real space R factor	Real space correlation coefficient	RMSZ-bond-length	RMSZ-bond-angle	Outliers of bond length	Outliers of bond angle	Atomic clashes	Stereochemical errors	Model completeness	Average occupancy
8AUN_L9I_A_502	74%	14%	0.095	0.924	1.75	2.1	3	3	0	0	100%	1
8AUN_L9I_B_502	72%	12%	0.096	0.92	1.82	2.28	3	3	0	0	100%	1
8AUJ_L9I_A_502	74%	13%	0.113	0.942	1.89	2.03	4	3	0	0	100%	1
8AUA_L9I_B_402	64%	12%	0.115	0.913	1.98	2.12	4	3	0	0	100%	1
8AUH_L9I_B_403	87%	26%	0.088	0.961	1.65	1.34	3	1	0	0	100%	0.489
8AUG_L9I_B_402	82%	27%	0.098	0.954	1.58	1.37	2	1	0	0	100%	0.552
8A8I_L9I_D_402	47%	11%	0.167	0.907	2.14	2.04	4	2	0	0	100%	0.209

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM157729.